Integrated Biopharma (INBP) Gross Profit (2010 - 2026)
Integrated Biopharma (INBP) reported Gross Profit of $28,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 98.1% from $1.47 million a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) Gross Profit (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma posted Gross Profit of $800,000, down 85.6% from FY2025.
- Gross Profit has a five-year compound annual growth rate of -39.0% (FY2021 to FY2026).
- By fiscal year, Gross Profit came in at $5.56 million in FY2025 (+43.2%), $3.88 million in FY2024 (-4.4%), $4.06 million in FY2023 (-38.0%) and $6.55 million in FY2022 (-30.9%).
- Five-year quarterly Gross Profit spans a low of -$276,000 in fiscal Q3 2026 and a high of $1.98 million in fiscal Q3 2022.
- Year over year, Gross Profit gained in four of the last seven quarters, with growth averaging 1.1%.
- The high point for year-over-year Gross Profit in five years was fiscal Q2 2025 (growth of 125.2%); the low point was fiscal Q4 2026 (a decline of 98.1%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$276,000 (Q3 2026), $29,000 (Q2 2026) and $1.02 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28,000.00 |
| Mar 31, 2026 | -276,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | 832,000.00 |
| Jun 30, 2023 | 986,000.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 997,000.00 |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.42 Mn |
API Access
Integrated Biopharma Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();